New York Medical College is a private biomedical health sciences university based in Valhalla, New York. Founded in 1860, it is a member of the Touro College and University System.

During the past decade, New York Medical College Division of Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New York Medical College Division of Oncology" are "Acute Myeloid Leukemia" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "New York Medical College Division of Oncology" in a lesser frequency.

Most popular intervention types in "New York Medical College Division of Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CPX-351" (1 trials), "Cytarabine" (1 trials), "Daunorubicin" (1 trials), "Forodesine Hydrochloride Capsules (100 mg)" (1 trials) and "Forodesine Hydrochloride Sterile Solution, 5 mg/mL" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Medical College Division of Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "New York Medical College Division of Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in New York Medical College Division of Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New York Medical College Division of Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".